BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED Jr, Gavioli EC. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel) 2021;14:775. [PMID: 34451872 DOI: 10.3390/ph14080775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Markiewicz-gospodarek A, Markiewicz R, Dobrowolska B, Rahnama M, Łoza B. Relationship of Neuropeptide S (NPS) with Neurocognitive, Clinical, and Electrophysiological Parameters of Patients during Structured Rehabilitation Therapy for Schizophrenia. JCM 2022;11:5266. [DOI: 10.3390/jcm11185266] [Reference Citation Analysis]
2 Markiewicz-Gospodarek A, Markiewicz R, Dobrowolska B, Maciejewski R, Łoza B. Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia. Brain Sci 2022;12:768. [PMID: 35741653 DOI: 10.3390/brainsci12060768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang J, Liu H, Jiang H. Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit. Front Aging Neurosci 2021;13:790224. [PMID: 34912210 DOI: 10.3389/fnagi.2021.790224] [Reference Citation Analysis]